argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Audition on April 25 for Algoma University’s Great Lakes International Summer Music Experience Program

Algoma University’s Great Lakes International Summer Music Experience is turning its Sault Ste. Marie campus into a two-week ...
The Lancet

Is partial complement blockade enough in myasthenia gravis?

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
eLife

mRNA Imprinting: transcription apparatus can remotely control cytoplasmic post-transcriptional mechanisms by dozens of proteins

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...

THE 100 BEST NEW HOTELS OF THE YEAR

These are the 100 best new hotels around the world, all visited by expert reporters and carefully reviewed by Travel + ...